Exicure Market Sentiment

Market sentiment signals for Exicure (XCUR): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— N/A

Short Interest▲ 1.2% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

—

Options Flow (P/C)

—

Avg Consensus PT

—

Highest Price Target

—

Lowest Price Target

—

Short Interest

1.2%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Insider & Market Activity News

PRO
Carlson Capital LP Reports 5% Passive Stake In Exicure As Of December 1

- Sec Filing

Benzinga Newsdesk

The Daily Biotech Pulse: CDC Recommends COVID-19 Boosters For Kids 5-11, Foghorn's Blood Cancer Trial On Clinical Hold, Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara

Here's a roundup of top developments in the biotech space over the last 24 hours:

Vandana Singh

PRO
Exicure Reports In Form4 Filing A Director Bought 1,472,126 Shares At Average Price Of $0.19/Share

Benzinga Newsdesk

Stocks That Hit 52-Week Lows On Friday

During Friday's session, 445 companies made new 52-week lows.

Benzinga Insights

Exicure Inc

Exicure Market Sentiment

Key Signals

Insider & Market Activity News

PRO
Carlson Capital LP Reports 5% Passive Stake In Exicure As Of December 1

The Daily Biotech Pulse: CDC Recommends COVID-19 Boosters For Kids 5-11, Foghorn's Blood Cancer Trial On Clinical Hold, Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara

PRO
Exicure Reports In Form4 Filing A Director Bought 1,472,126 Shares At Average Price Of $0.19/Share

Stocks That Hit 52-Week Lows On Friday

People Also Watch

People Also Watch

Exicure Inc

Exicure Market Sentiment

Key Signals

Insider & Market Activity News

PROCarlson Capital LP Reports 5% Passive Stake In Exicure As Of December 1

The Daily Biotech Pulse: CDC Recommends COVID-19 Boosters For Kids 5-11, Foghorn's Blood Cancer Trial On Clinical Hold, Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara

PROExicure Reports In Form4 Filing A Director Bought 1,472,126 Shares At Average Price Of $0.19/Share

Stocks That Hit 52-Week Lows On Friday

People Also Watch

People Also Watch

PRO
Carlson Capital LP Reports 5% Passive Stake In Exicure As Of December 1

PRO
Exicure Reports In Form4 Filing A Director Bought 1,472,126 Shares At Average Price Of $0.19/Share